合計 48 件の最近のインサイダー取引記録が記録されています Indivior Pharmaceuticals Inc (INDV), 内訳は 25 件の買い および 5 件の売り. インサイダー買い総額は $203.61K インサイダー売り総額は RSU アワード.
最近活動のある主要インサイダーには Barry Patrick A, Ciaffoni Joseph, Burris Jeffrey W. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — INDV
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2028-06-02 |
Barry Patrick A |
Chief Commercial Officer |
不明 |
130,312 |
- |
- |
- |
| 2028-05-08 |
Ciaffoni Joseph |
Chief Executive Officer |
不明 |
422,302 |
- |
- |
- |
| 2028-03-07 |
Burris Jeffrey W |
Chief Legal Officer |
不明 |
71,743 |
- |
- |
- |
| 2028-03-07 |
Anderson Woodrow D |
Chief Accounting Officer |
不明 |
29,478 |
- |
- |
- |
| 2028-03-07 |
Heidbreder Christian |
Chief Scientific Officer |
不明 |
82,287 |
- |
- |
- |
| 2028-03-07 |
Preblick Ryan |
Chief Financial Officer |
不明 |
70,459 |
- |
- |
- |
| 2026-03-14 |
Preblick Ryan |
Chief Financial Officer |
オプション行使(売却) |
6,302 |
- |
- |
- |
| 2026-03-13 |
Ryan Barbara |
Director |
情報に基づく買い |
8 |
$31.09 |
$248.68 |
5,724 |
| 2026-03-09 |
Ryan Barbara |
Director |
情報に基づく買い |
31 |
$32.56 |
$1.01K |
5,716 |
| 2026-03-06 |
Kingsley Stuart A |
Director |
情報に基づく買い |
940 |
$31.87 |
$29.95K |
5,582 |
| 2026-03-03 |
Burris Jeffrey W |
Chief Legal Officer |
オプション行使(売却) |
104,300 |
- |
- |
- |
| 2026-03-03 |
Anderson Woodrow D |
Chief Accounting Officer |
オプション行使(売却) |
5,946 |
- |
- |
- |
| 2026-03-03 |
Heidbreder Christian |
Chief Scientific Officer |
オプション行使(売却) |
132,565 |
- |
- |
- |
| 2026-03-03 |
Preblick Ryan |
Chief Financial Officer |
オプション行使(売却) |
113,510 |
- |
- |
- |
| 2026-02-10 |
Ciaffoni Joseph |
Chief Executive Officer |
RSU 付与(制限付株式) |
79,976 |
- |
- |
135,976 |
| 2026-02-10 |
Burris Jeffrey W |
Chief Legal Officer |
RSU 付与(制限付株式) |
26,897 |
- |
- |
27,657 |
| 2026-02-10 |
Barry Patrick A |
Chief Commercial Officer |
RSU 付与(制限付株式) |
31,380 |
- |
- |
31,380 |
| 2026-02-10 |
Anderson Woodrow D |
Chief Accounting Officer |
RSU 付与(制限付株式) |
6,903 |
- |
- |
11,293 |
| 2026-02-10 |
Heidbreder Christian |
Chief Scientific Officer |
RSU 付与(制限付株式) |
33,622 |
- |
- |
190,762 |
| 2026-02-10 |
Preblick Ryan |
Chief Financial Officer |
RSU 付与(制限付株式) |
37,358 |
- |
- |
317,940 |
| 2026-02-09 |
Burris Jeffrey W |
Chief Legal Officer |
RSU 付与(制限付株式) |
104,300 |
- |
- |
104,300 |
| 2026-02-09 |
Anderson Woodrow D |
Chief Accounting Officer |
RSU 付与(制限付株式) |
23,975 |
- |
- |
23,975 |
| 2026-02-09 |
Heidbreder Christian |
Chief Scientific Officer |
RSU 付与(制限付株式) |
132,565 |
- |
- |
132,565 |
| 2026-02-09 |
Preblick Ryan |
Chief Financial Officer |
RSU 付与(制限付株式) |
113,510 |
- |
- |
113,510 |
| 2026-01-26 |
Ninivaggi Daniel A |
Director |
RSU 付与(制限付株式) |
3,722 |
- |
- |
20,645 |
| 2026-01-26 |
Kingsley Stuart A |
Director |
RSU 付与(制限付株式) |
3,722 |
- |
- |
4,642 |
| 2026-01-26 |
Stejbach Mark |
Director |
RSU 付与(制限付株式) |
3,722 |
- |
- |
20,569 |
| 2026-01-26 |
Thompson Juliet |
Director |
RSU 付与(制限付株式) |
3,722 |
- |
- |
7,572 |
| 2026-01-26 |
Wheadon David E. |
Director |
RSU 付与(制限付株式) |
5,955 |
- |
- |
20,350 |
| 2026-01-26 |
Ryan Barbara |
Director |
RSU 付与(制限付株式) |
3,722 |
- |
- |
5,685 |
| 2026-01-26 |
Humphreys Keith |
Director |
RSU 付与(制限付株式) |
3,722 |
- |
- |
9,524 |
| 2026-01-05 |
Ninivaggi Daniel A |
Director |
情報に基づく買い |
775 |
$35.39 |
$27.43K |
16,923 |
| 2026-01-05 |
Stejbach Mark |
Director |
情報に基づく買い |
775 |
$35.39 |
$27.43K |
16,847 |
| 2026-01-05 |
Wheadon David E. |
Director |
情報に基づく買い |
1,771 |
$35.39 |
$62.68K |
14,395 |
| 2026-01-05 |
Ryan Barbara |
Director |
情報に基づく買い |
775 |
$35.39 |
$27.43K |
1,963 |
| 2026-01-05 |
Humphreys Keith |
Director |
情報に基づく買い |
775 |
$35.39 |
$27.43K |
5,802 |
| 2026-01-01 |
Ninivaggi Daniel A |
Director |
不明 |
- |
- |
- |
16,148 |
| 2026-01-01 |
Kingsley Stuart A |
Director |
不明 |
- |
- |
- |
920 |
| 2026-01-01 |
Ciaffoni Joseph |
Chief Executive Officer |
不明 |
1,266,903 |
- |
- |
- |
| 2026-01-01 |
Burris Jeffrey W |
Chief Legal Officer |
不明 |
- |
- |
- |
760 |
| 2026-01-01 |
Stejbach Mark |
Director |
不明 |
- |
- |
- |
16,072 |
| 2026-01-01 |
Thompson Juliet |
Director |
不明 |
- |
- |
- |
3,850 |
| 2026-01-01 |
Wheadon David E. |
Director |
不明 |
- |
- |
- |
12,624 |
| 2026-01-01 |
Ryan Barbara |
Director |
不明 |
- |
- |
- |
1,188 |
| 2026-01-01 |
Anderson Woodrow D |
Chief Accounting Officer |
不明 |
- |
- |
- |
4,390 |
| 2026-01-01 |
Heidbreder Christian |
Chief Scientific Officer |
不明 |
- |
- |
- |
157,140 |
| 2026-01-01 |
Preblick Ryan |
Chief Financial Officer |
不明 |
- |
- |
- |
280,582 |
| 2026-01-01 |
Humphreys Keith |
Director |
不明 |
- |
- |
- |
5,027 |
■ 情報付き — 公開市場取引(最も重要)
■ 情報なし(買い) — 報酬・オプション行使・転換
■ 情報なし(売り) — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効